Carregant...
Acute myeloid leukemia targets for bispecific antibodies
Despite substantial gains in our understanding of the genomics of acute myelogenous leukemia (AML), patient survival remains unsatisfactory especially among the older age group. T cell-based therapy of lymphoblastic leukemia is rapidly advancing; however, its application in AML is still lagging behi...
Guardat en:
| Publicat a: | Blood Cancer J |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5386336/ https://ncbi.nlm.nih.gov/pubmed/28157217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2017.2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|